The Discounted Cash Flow (DCF) valuation of Zhejiang Medicine Co Ltd (600216.SS) is 14.42 CNY. With the latest stock price at 13.65 CNY, the upside of Zhejiang Medicine Co Ltd based on DCF is 5.6%.
Based on the latest price of 13.65 CNY and our DCF valuation, Zhejiang Medicine Co Ltd (600216.SS) is a buy. buying 600216.SS stocks now will result in a potential gain of 5.6%.
| Range | Selected | |
| WACC / Discount Rate | 8.1% - 11.3% | 9.7% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 10.90 - 22.96 | 14.42 |
| Upside | -20.2% - 68.2% | 5.6% |